|
CUL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.72820000035701E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.46939999999363E-05 |
| Normal-vs-Stage2 |
1.203430E-04 |
| Normal-vs-Stage3 |
1.97400000012671E-07 |
| Normal-vs-Stage4 |
4.86000000243791E-08 |
| Stage1-vs-Stage2 |
3.182000E-01 |
| Stage1-vs-Stage3 |
5.954100E-02 |
| Stage1-vs-Stage4 |
9.381000E-03 |
| Stage2-vs-Stage3 |
7.347800E-01 |
| Stage2-vs-Stage4 |
3.555400E-01 |
| Stage3-vs-Stage4 |
4.588000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.96919999990209E-08 |
| Normal-vs-AfricanAmerican |
1.176960E-01 |
| Normal-vs-Asian |
2.366900E-04 |
| Caucasian-vs-AfricanAmerican |
6.502000E-02 |
| Caucasian-vs-Asian |
6.346400E-01 |
| AfricanAmerican-vs-Asian |
1.991980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.2620999995393E-07 |
| Normal-vs-Female |
1.69449999998239E-06 |
| Male-vs-Female |
3.927600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.202050E-04 |
| Normal-vs-Age(41-60Yrs) |
4.99700000045067E-07 |
| Normal-vs-Age(61-80Yrs) |
4.26499999983676E-07 |
| Normal-vs-Age(81-100Yrs) |
1.365970E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.534200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.158300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.843400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.194200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.017800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.446000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.475700E-02 |
| Classical-VS-Follicular |
9.861800E-02 |
| Classical-VS-Other |
1.425380E-01 |
| Classical-VS-Normal |
2.01909999999472E-05 |
| Tall-VS-Follicular |
5.010800E-01 |
| Tall-VS-Other |
6.338600E-01 |
| Tall-VS-Normal |
4.05329999997317E-06 |
| Follicular-VS-Other |
5.238600E-01 |
| Follicular-VS-Normal |
2.27599999998995E-05 |
| Other-VS-Normal |
3.495800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.08170000001628E-06 |
| Normal-vs-N1 |
3.60579999969524E-07 |
| N0-vs-N1 |
2.105400E-01 |
|
|
